| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CSO &EVP Pre-clinical Dev
1 company
David Eric is a CSO &EVP Pre-clinical Dev at VIVS. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $309K at current prices.
David Eric's largest disclosed position is in VIVS as CSO &EVP Pre-clinical Dev, worth about $309K. The recent filings there lean toward selling, a net 20,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2016 | VIVS Vivosim Labs, Inc. | CSO &EVP Pre-clinical Dev | Sell | 20,000 | $4.55 | $91,000.00 | -2.8% |